The Miracle Molecule

This is your chance to get in on a pre-IPO medical marijuana company with patented game-changing technology before it goes public. The Miracle Molecule [Nick Hodge Photo] By [Nick Hodge]( Written Wednesday, July 26, 2017 Last week I discussed with you how mainstream IPOs can be a dangerous game for retail investors. In a nutshell, many companies that come to trade have already been funded several times at lower valuations. So once they come to trade, much of the value has already been gobbled up by the time the public has the chance to buy them. For the past two years, I've been bringing investors to the other side of that equation: We've been funding companies privately, early in their life cycles, and before they come to trade publicly. The gains in doing so have been phenomenal. In fact, I would put my track record up against anyone in the industry with great confidence. We privately financed a lithium company that ran from the 15 cents we paid for it... to $2.50 after it began trading. Advertisement [Is This $2 Stock The Next Genentech?]( In the mid 1970s diabetes was an enormous market, but no one could treat it. Then Genentech invented synthetic insulin — propelling it to a $100 billion market cap. It would go down in history as one of Silicon Valley’s greatest success stories. Now you can buy the next Genentech at a valuation of just $20 million. Only this time — it's tackling an even bigger market. [Get all the details immediately.]( We put money into a gold company that went from 35 cents when we financed it privately to over $2.20 when it began trading. These are giant wins. And I was one of the first writers to start bringing deals like this to investors like you. Prior to that, private investments like this were largely off limits. I also told you last week that I would soon be unveiling our next pre-IPO investment — a rising star in the field of medical marijuana and beyond. Yesterday, I met with company representatives at the Fairmont Vancouver over breakfast. And I'm highly confident it will be our next big win. In short, this company has patented a new way to deliver cannabidiol (CBD) to the body. Advertisement Big Energy’s Eco-Friendly Secret...]( It’s not solar, or wind, or thermal... or anything you’ve seen on CNN. The technology I’m referring to is known as [Fracking 2.0.]( Now one tiny Texas company is using it to suck barrel after barrel of “emission-free oil” right out of the ground. The resource it's unlocked is so big... it's now the energy equivalent of Norway. [Watch our special report for details...]( CBD has been hailed as a wonder drug by doctors across the world. It is being used to treat a wide variety of illnesses and afflictions. Doctors and scientists are using terms like “miracle molecule” and “molecule of the century.” But it has one big problem: CBD is lipophilic. That's the fancy way of saying that it's only soluble in fat. Because of that, your liver screens it out. Your blood is water-based, and your liver literally rejects anything that isn't water-based. So once the drug is delivered, it's filtered out in a few hours before it has the chance to work effectively. This means doctors need to give you much more of it to be effective, thereby increasing costs. This is a problem many drug companies are trying to solve. But only one has: the company we are privately funding this week. It has a patented way to wrap the CBD molecule in a nano-shell to “trick” the body into thinking it's water-based so the liver doesn't reject it. This isn't stoner stuff. This was developed at a top university. And I believe it's going to be majorly disruptive in the industry. Companies with a single CBD drug are fetching $300 million to $1 billion valuations in the market. [This company]( has a way to make all CBD drugs more effective. What is that worth? Right now, the company is private. It has ~8 million shares out and is raising money at $2.00. That means it has a tiny ~$16 million valuation. Getting a $300 million valuation would be 18x your money. A $1 billion valuation would be over 62x your money. That's why getting in before stocks start trading is so important. Advertisement My team of researchers recently uncovered [a key patent that exposes a major chink in Tesla’s armor...]( This patent describes a groundbreaking technology that could simply blow Elon Musk, and frankly the entire solar industry, out of the water. We’ve managed to uncover the tiny company with exclusive rights to this technology. It trades at less than $0.15 a share, but don’t expect it to stay there for long. Over the next several years, I believe the value of this firm could absolutely explode... [by my calculations, upwards of 4,600%.]( I’ve included the patent filing and everything you need to know about this small company in this brief, [free video presentation.]( With the money it's raising right now, it plans to enter trials. And once it does it plans to IPO on a major exchange. This is your chance to get in on a pre-IPO medical marijuana company with patented game-changing technology before it goes public. The deal is closing shortly. [Full details are here.]( Call it like you see it, [Nick Hodge Signature] Nick Hodge [[follow basic]@nickchodge on Twitter]( Nick is the founder and president of the [Outsider Club](, and the investment director of the thousands-strong stock advisories, [Early Advantage]( and [Wall Street's Underground Profits](. He also heads [Nick’s Notebook](, a private placement and alert service that has raised tens of millions of dollars of investment capital for resource, energy, cannabis, and medical technology companies. Co-author of two best-selling investment books, including Energy Investing for Dummies, his insights have been shared on news programs and in magazines and newspapers around the world. For more on Nick, take a look at his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [This Ship is Sailing, With or Without You]( [Ignore the Posers, Here's the Real Deal...]( [Circling the drain in the most expensive stock market in the world]( [Don't Get Hosed by IPOs]( [Why Nevada Pot Dealers Are Freaking Out]( Related Articles [How to Invest in Quality Private Placements]( [Don't Get Hosed by IPOs]( [Ignore the Posers, Here's the Real Deal...]( --------------------------------------------------------------- This email was sent to {EMAIL} . It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add ww-eletter@angelnexus.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2017, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.